HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves

August 12, 2014 By Brad Perriello

HeartWare International (NSDQ:HTWR) said it recruited the former medical chief at JenaValve, Dr. Katrin Leadley, to be its new CMO effective Sept. 1.

Leadley, who spent the last 3 years running JeneValve’s clinical program and regulatory strategy, will replace Dr. David Hathaway, who plans to retire, according to a press release. She joined JenaValve from Boston, where she spent 8 years working in its cardiovascular segment, after stints at Advanced Stent Technologies, Pulmonx and Quintiles/The Lewin Group, according to the release.

"Katrin has a wealth of clinical program management experience, and we are confident she will be a great addition to our team," president & CEO Doug Godshall said in prepared remarks. "Her knowledge of cardiovascular device trials and her relationships with many of our international key opinion leaders will enable her to begin making contributions immediately. Katrin has proven experience in identifying new market opportunities, ensuring patient safety and executing clinical development plans and regulatory strategies to achieve product approvals and market introductions of new medical therapies. Katrin will help lead HeartWare through our next stage of clinical and commercial growth, as we advance our ongoing trials, initiate new studies and move toward obtaining regulatory approval of devices in our pipeline.

"HeartWare would like to recognize and express our gratitude toward Dr. David Hathaway who has provided excellent stewardship during the past six years," Godshall added. "Dave has played an integral role in leading us through the clinical process to obtain regulatory approval of the HeartWare ventricular assist system in Europe and as a bridge-to-transplantation therapy in the U.S. HeartWare values Dave’s numerous, meaningful contributions and wishes him well in his retirement, as our organization continues to grow and build upon the foundation he helped us create."

JenaValve last month named ex-AtriCure chief David Drachman as its new CEO.

AngioDynamics eliminates CTO/COO role

AngioDynamics (NSDQ:ANGO) said it’s eliminating the position of chief technology & operations officer, which was held by George Bourne. He is slated to stay on until Sept. 12 and to receive his current salary and benefits for a year after that, AngioDynamics said.
Read more

NuVasive names Blackford new CFO
NuVasive Inc. (NSDQ:NUVA) said it named Quentin Blackford to be its new CFO and accounting chief, replacing Michael Lambert, who retired July 31. Lambert is slated to stay on as an advisor through March 15, 2015, NuVasive said.
Read more

Orgenesis names Carmer as North American CEO
Orgenesis said it named (NYSE:AZN) veteran Scott Carmer as its new CEO for North America.
Read more

Revolutions Medical COO Olmo retires
Revolutions Medical (PINK:RMCP) said its operations chief, Vincent Olmo, retired July 31.
Read more

MIT researchers may have invented a safer way of splitting ventilators
MIT and Brigham and Women’s Hospital researchers say they have a way of splitting ventilators which could address many of the safety concerns — potentially boosting the supply of ventilators amid the COVID-19 pandemic. They have demonstrated their concept’s effectiveness in the lab — but they still caution it should be used only as a… […]
What is a pulse oximeter — and how does it work?
If you’re recovering from a respiratory problem — including COVID-19 — chances are you may have had your oxygen levels checked with a pulse oximeter. Pulse oximetry is the non-invasive measurement of oxygen saturation (SpO2). Oxygen saturation is defined as the amount of oxygen dissolved in the blood, based on the detection of Hemoglobin, Hb,… […]
Tegra Medical CEO to retire
Tegra Medical announced today that CEO J. Mark King will retire on Aug. 1, 2020. King is also retiring from his position as head of the medical division within the SFS Group, which acquired Tegra in 2016. King joined Tegra in 2012 as chief operating officer with more than 20 years of operations, sales, engineering… […]
Steris wins second EUA to decontaminate up to 30m respirators per day
Steris (NYSE:STE) has won an FDA emergency use authorization (EUA) for a new steam sterilization method to decontaminate used N95 respirators. The EUA covers the new Steris Steam Decon cycle to decontaminate 3M 1860, 3M 1860S, and 3M 1804 NIOSH-approved N95 respirators that are or might be contaminated with SARS-CoV-2 and other pathogenic microorganisms. The FDA… […]
Raumedic supplies adhesive for production of thousands of ventilators
When the federal government tapped Hamilton Medical to produce tens of thousands of ventilators for COVID-19 patients, the company turned to its long-term partner Raumedic for a special silicone adhesive. The adhesive is solvent- and plasticizer-free, easy to use and bonds silicones to each other and to other materials, such as metal or plastics, according… […]
FDA signals PPE shortage, issues EUA for more
The FDA has issued a call for manufacturers to produce more non-surgical gowns and other personal protective equipment (PPE) as the coronavirus pandemic makes its way across the country. The emergency use authorization issued Friday also listed conductive shoes and shoe covers, operating room shoes and shoe covers, surgical helmets and caps and other surgical accessories. The… […]
Ga. warehouse workers sue Sterigenics, ConMed over EtO exposure
Fifty-three people who worked in an Atlanta-area warehouse that stored medical devices sterilized by ethylene oxide (EtO) filed suit this week against Sterigenics and its parent company over exposure to the gas. The plaintiffs or their families claim that long-term EtO exposure to the sterilized devices, which they unloaded, handled, warehoused and distributed, caused multiple… […]
FDA eases regs on certain device changes during pandemic
The FDA will allow limited changes to certain devices so medtech companies can address manufacturing and supply chain issues due to COVID-19-related disruptions. In a guidance released yesterday, the agency said it would allow changes to devices approved through its premarket approval (PMA) and humanitarian device exemption (HDE) pathways as long as those changes do… […]
15 heart devices that could boost their manufacturers’ sales
Before the coronavirus pandemic hit, medtech companies large and small were making notable news with a number of innovative heart devices. Some of these same companies took a big hit to their bottom lines when the danger of spreading COVID-19 and using up precious personal protective equipment convinced hospitals to limit non-urgent procedures. Now hospitals… […]
This wearable could help people practice safe distancing amid COVID-19
Imec spinoff Lopos, with the Ghent University (Belgium) announced the Lopos SafeDistance wearable for promoting safety during the COVID-19 pandemic. As businesses attempt to return to in-person activities, the collaboration designed the wearable device to warn employees through an audible or haptic alarm when they are violating social distancing guidelines as they approach each other.… […]
FDA launches COVID-19 research initiative
The FDA has entered an agreement with healthcare analytics company Aetion to research urgent questions about COVID-19. The New York City-based company said the research will support FDA objectives to explore the natural history of the disease, as well as treatment and diagnostic patterns using relevant, novel data sources and analyzing these data according to well-established principles.… […]